Related Experiment Video
Updated: Jun 3, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 11, 2013
Respiratory Syncytial Virus Vaccination in Pregnancy and Social Determinants of Health
Meralis Lantigua-Martinez1, Cody Goldberger2, Rosanne Vertichio3
1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, NYU Langone Health, New York, New York.
Abstract:
Social determinants of health (SDOH) may impact the incidence of respiratory syncytial virus (RSV) infection and the uptake of vaccinations in pregnancy. The objective of this study is to identify contributors to disparities in RSV vaccination in pregnancy.This is a retrospective cohort study of patients delivering at term within three hospitals during February and March 2024, comparing pregnant patients identified as receiving versus not receiving RSV vaccinations. This period and gestational age were chosen to include patients who would have qualified for RSV vaccination administration. Vaccination status was extracted from standardized admission templates where these variables were recorded as discrete fields. Patients without RSV vaccination information were excluded. Sociodemographic factors, COVID-19 vaccination status, and delivery campus were evaluated. Outcomes were analyzed using chi-squared, t-test, and McNemar test.A total of 2,181 patients met inclusion criteria and RSV vaccination information was available for 1,548 patients (71%) with a 14% vaccination rate. Compared with those not vaccinated (n = 1,332), RSV-vaccinated patients (n = 216) were more likely to be older (30.7 vs. 34.8, p < 0.001), have private insurance (42 vs. 85%, p < 0.001), speak English (82 vs. 95%, p < 0.001), and deliver at our regional perinatal center (26 vs. 77%, p < 0.001). Fifty percent of RSV-vaccinated patients had a history of COVID-19 vaccination compared with 33% of those not vaccinated against RSV (p < 0.001).SDOH was associated with differences in RSV vaccination status. In addition, patients without RSV vaccination were less likely to have had COVID-19 vaccination. These findings highlight the need to address SDOH to increase vaccination rates for vulnerable populations. · The rate of RSV vaccination in pregnant patients is low.. · Patients vaccinated against RSV tended to be older, privately insured, and English-speaking.. · SDOH and COVID-19 vaccination status are associated with RSV vaccination rates..
Related Concept Videos
Vaccinations
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Development of the Oral Microbiota
Respiratory Syncytial Virus Disease

